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Coxiella burnetii seroprevalence in the rural part of
Bolu, Turkey*
Aim: This study was performed to determine the seroprevalence of Coxiella burnetii in the rural part
of Bolu, a city located in the western part of the Black Sea region of Turkey.
Materials and Methods: The study population was chosen by cluster sampling to represent the rural
population of the city. Serum samples were collected from the 9 rural districts of Bolu. Blood samples
were taken to the laboratory while stored at 4 °C in ice-cooled boxes. The sera were then stored at
−20 °C until testing. The presence of IgG antibodies against C. burnetii phase-II antigens in the sera
was determined using IFA.
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Results: The study included 293 cases and C. burnetii phase-II IgG was positive in 61 of the subjects
(20.8%). The seroprevalence of C. burnetii was 23.8% (59/248) among the participants above 18 years
of age and 4.4% (2/45) among those younger than 18 years of age (P < 0.01). There was a significant
relationship between C. burnetii seropositivity and direct contact with the birth products of farm
animals (P < 0.001); however, there was not a significant difference between genders.
Conclusions: Although the seroprevalence rate was high, Q fever was underreported and
unrecognized in rural Bolu. We conclude that Q fever must be considered in patients with a suitable
clinical course in this region.
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Türkiye’nin Bolu ili kırsalında Coxiella burnetii
seroprevalansının araştırılması
Amaç: Bu çalışmada Türkiye’nin Batı Karadeniz bölgesinde yer alan Bolu’nun kırsal bölgesinde
Coxiella burnetii seroprevalansının belirlenmesi amaçlandı.
Yöntem ve Gereç: Çalışma popülasyonu Bolu’nun kırsal ilçelerini de temsil edebilmek amacıyla
tabakalı örnekleme yöntemine göre belirlendi. Bolu’nun 9 ilçesinden serum örnekleri toplandı. Kan
örnekleri +4 °C lik buzlu kutularda laboratuvara getirildi. Serum örnekleri ayrılarak çalışma
zamanına kadar −20 °C ‘de saklandı. Hastalardan alınan serum örneklerinden IFA yöntemiyle C.
burnetii faz II antijenlerine karşı oluşan IgG antikorlarının varlığı araştırıldı.
Bulgular: Çalışmaya 293 olgu dahil edildi. Olguların 61’inde (% 20,8) C. burnetii faz II IgG pozitifliği
saptandı. Coxiella burnetii seroprevalansı 18 yaş üzerindeki olgularda % 23,8 (59/248) ve 18 yaş
altındakilerde % 4,4 (2/45) idi (P < 0,01). Coxiella seropozitifliği ve hayvanların gebelik ürünleriyle
temas etme arasında istatistiksel anlamlı ilişki saptanmışken (P < 0,001), cinsiyetle Coxiella burnetii
seropozitifliği arasında anlamlı bir ilişki saptanmadı.
Sonuç: Yüksek Coxiella seroprevalansına rağmen bölgemizdeki olgulara Q ateşi tanısı
konulamamakta ve bildirim yapılmamaktadır. Bölgemizde yaşayan hastalardan, Coxiella
enfeksiyonuyla uyumlu klinik seyir gösteren hastalarda, Q ateşinin ayırıcı tanıda düşünülmesi
gerektiği kanısındayız.
Anahtar sözcükler: Coxiella burnetii, seroprevalans, Bolu, Türkiye

* This study was funded by Abant İzzet Baysal University (ABU-BAP-Project No: 2005.08.03.210) and was presented at the 17th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID), Munich,
Germany, 31 Mar - 04 April 2007.
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Introduction
Coxiella burnetii is a small (0.3-0.7 μm) gramnegative coccobacillus. It is the etiological agent of Q
fever. Q fever is a zoonosis that can be transmitted to
humans by infected sheep, goats, and cattle (1). It is
resistant to environmental conditions, and both
chemical and physical inactivation due to the
formation of metabolically inactive small cell variants.
It can survive at 60 °C for 60 min and in a 5% formalin
solution for 4 h. Infection in humans occurs primarily
after inhalation of aerosolized organisms. Infection
can be transmitted via the urine, feces, milk, and
delivery products of infected animals. For this reason
Q fever is most commonly seen in rural parts of
Turkey and primarily in breeders of farm animals (2).
Q fever is an acute infection that rarely becomes
chronic. Symptoms of Q fever include fever with
chills, headache, malaise, myalgia, and rarely atypical
pneumonia, hepatitis or meningoencephalitis.
Nonetheless, 60% of those infected with this agent are
asymptomatic (3).
Only a few studies have investigated the prevalence
of Q fever in Turkey and the seropositivity rate of C.
burnetii was reported to be between 7.1% and 39.3%
(4,5). Due to the lack of specific clinical signs and
symptoms of disease, it is impossible to estimate the
true incidence in Turkey, including the Bolu region.
With the present study we aimed to determine the
seroprevalence of C. burnetii in children and adults in
the rural part of Bolu, which is located in the Black
Sea region of Turkey, using the indirect
immunofluorescence antibody method.
Materials and methods
Ethical approval
This study was approved by the Abant İzzet Baysal
University Ethics Committee. Informed consent was
obtained from each subject or their parents, in the
case of children.
The city
Bolu is a city located in the western part of the
Black Sea region of Turkey, with a population of
270,654 according to the general population census of
2000. It has 9 districts in which cattle and sheep
breeding is a common activity.
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Sample size
The study population was chosen by cluster
sampling to represent the rural population of the city.
Samples were chosen according to the population
ratio of each district based on the general population
census of 2000. The following formula was used to
determine the sample size (6)
N.t2.p.q
n=
d2.(N–1)+t2.p.q
In this formula N represents the population size, t
is the constant (1.96), and p is the a priori assumption
of the population parameter (0.28 according to the
results of recent studies in Turkey), q is equal to 1 - p,
and d is the margin of error (2%).
According to the formula, a minimum of 220
subjects were necessary. The sample size from each
district was determined by the relative proportion of
the population density of the district.
Questionnaire and laboratory tests
Each subject completed a questionnaire that
collected data on demographic parameters, and
involvement with animal birth products, milking,
inhalation of stable dust, assisting in the birth of
animals, and tick bites. Afterwards, 10 mL of venous
blood was obtained from each participant. These
blood samples were immediately transferred to the
microbiology laboratory of Abant İzzet Baysal
University, Faculty of Medicine. The blood samples
were taken to the laboratory in 4-°C iced-cooled
boxes. Blood samples were centrifuged and the sera
were separated and stored at –20 °C until analysis.
The presence of IgG antibodies against C. burnetii
phase II antigens was measured using a commercially
available indirect immunofluorescence antibody
(IFA) (Vircell, Spain), according to the manufacturers’
recommendations. A titer of at least 1/64 was
considered positive.
Statistical analysis
Statistical analysis was performed using Epi Info
v.6.0 (CDC, Atlanta, GA, USA). Explanatory variables
were tested for their associations with the serological
status using the χ2 test, or, when appropriate, Fisher’s
exact test.
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Results

Discussion

In all, 311 serum samples were collected from the
9 districts of Bolu; however, 18 samples were excluded
because of hemolysis and sample tube breakage. The
remaining 293 samples (248 adult and 45 children)
were included in the study. Of the 293 subjects, 128
(43.6%) were male and 165 (56.4%) were female. Age
range of the participants was 2-82 years.

C. burnetii causes highly variable clinical
manifestations, ranging from asymptomatic to acute,
fatal, or chronic infection; however, about 60% of
patients are asymptomatic (7). For this reason the
disease is not very well recognized and remains
undiagnosed throughout the world. According to
studies from Turkey, the seropositivity rate for C.
burnetii ranges from 7.1% to 39.3% (4-6,8). In the
present study 20.8% of a sample population
representative of the rural area of Bolu had antibodies
against C. burnetii, which suggests the endemic nature
of this infection in the study region. Our results are in
agreement with those obtained in previous studies in
Turkey. We know that, according to official sources,
no case has been reported in Bolu until this study.
According to these results, we think that Q fever is
undiagnosed in Bolu, as it is in most regions of
developing countries.

According to the test results, 61 (20.8%) samples
were positive for C. burnetii phase II antibodies. Of
these 61 positive samples, 59 (23.8%) belonged to
participants older than 18 years of age and 2 (4.4%)
belonged to participants younger than 18 years (P <
0.001). In all, 19.3% of the females and 22.6% of the
males tested positive. Exclusion of children from the
analysis increased the prevalence rate (22.6% in
females vs. 25.2% in males), but did not change the
significance of difference between genders (P > 0.05).
A history of contact with animal birth products
was significantly related to C. burnetii seropositivity
(Table). Demographic and clinical features of the
subjects are presented in the Table.

Q fever prevalence studies in the pediatric
population are limited in Turkey; therefore, we
included a pediatric group in the present study. Mean

Table. Demographic and clinical characteristics of the subjects.
Parameters

Coxiella burnetii
IgG positive
n = 61 (%)

Coxiella burnetii
IgG negative
n = 232 (%)

P

32/29

133/99

*

40.8 [5-81]

39.7 [2-82]

*

Adult patients (age ≥ 18 years, n = 248)

59 (96.7)

189 (81.4)

Pediatric patients (age < 18 years, n = 45)

2 (3.3)

43 (18.6)

Inhalation of stable dust extract

43 (70.5)

156 (67.2)

*

Headache

26 (42.6)

96 (41.3)

*

Arthralgia

27 (44.2)

83 (35.7)

*

Cough

19 (31.1)

42 (18.1)

0.02

Fever

7 (11.4)

37 (15.9)

*

Tick bite

4 (6.6)

21 (9.1)

*

Milking

32 (52.5)

103 (44.4)

*

Contact with animal birth products

30 (48.3)

54 (23.2)

< 0.001

Gender (female/male)
Mean age (range)

< 0.01

OR

6.71 (1.53-41.32)

2.05 (1.03-4.05)

6.90 (3.48-13.73)

*P > 0.05.
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age of C. burnetii seropositive participants was 40.8
years. C. burnetii seropositivity increased from 4.4%
(2 children [5 and 6 years old] were positive) among
those younger than 18 years of age to 23.8% among
those older than 18 years of age. This result confirms
that exposure to C. burnetii occurs mainly after 20
years of age. Similarly, Cardenosa et al. reported that
the seroprevalence of C. burnetii was 0% among those
younger than 14 years of age and 9.1% among those
between 15 and 29 years of age (9). Different
C. burnetii seroprevalence rates were reported in
children by seroepidemiological studies (10-12). The
differences may be the result of increased exposure to
infected animals with age.
It is known that increased exposure to farm
animals due to travel to rural areas, outdoor activities,
contact with pets, urbanization of rural areas, and
windborne spread may contribute to the increased
infection rates among urban residents. It is well
known that the aerosol route is the primary mode of
human C. burnetii infection (9). Contamination by
C. burnetii aerosols may occur directly from
parturient fluids of infected animals, which may infect
newborn animals and the placenta (3,13). Ergonul et
al. reported that C. burnetii seropositivity was 7.5% in
veterinarians in 2 cities in Turkey and that C. burnetii
seropositivity was not higher than in the general
population (14). Nonetheless, assisting in the birth of
animals without the help of a veterinarian is a
common practice in rural areas of Turkey. In the
present study the seroprevalence rate was 6.9-fold
higher (range: 3.48%-13.73%) among subjects that
had contact with animal birth products (Table). This
finding supports the notion that people in close
contact with animal birth products, like farmers,
veterinarians, and abattoir workers, have increased
risk of infection.
It was reported that contact with raw milk was
probably a minor factor in the transmission of
C. burnetii (15). Although C. burnetii was isolated
from arthropods, arthropod-borne transmission of Q
fever in humans is not likely to be important (3). In
the present study we did not find any relationship
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between tick bites, milking, or inhalation of stable
dust extract, and C. burnetii seropositivity, and C.
burnetii seropositivity was not associated with gender.
A significant difference was not observed between
such symptoms as headache, arthralgia, and fever, but
there was a significant difference between C. burnetii
seropositive and seronegative groups in terms of
cough (Table). The 3 main symptoms of Q fever
infection are pneumonia, flu-like syndrome, and
hepatitis. C. burnetii should be considered in the
differential diagnosis of patients with cough and
respiratory symptoms in the Bolu region.
The present study has some limitations. First, we
did not test cross-reactions among relevant
pathogens, for example Bartonella spp., Legionella
spp., or Chlamidya spp. Second, according to the
literature we used a low cut-off value (titer Ig G ≥
1/64). If 1/128 had been selected rather than 1/64,
then the seroprevalence would have been lower;
however, the 1/64 value has been used in other studies
(16,17).
Conclusions
C. burnetii seroprevalence was 20.8% in the rural
area of Bolu and seroprevalence increased with age.
Although the C. burnetii seroprevalence rate was high,
Q fever was unrecognized and underreported in Bolu.
Therefore, physicians and local health departments
must consider this important and prevalent infectious
agent, and Q fever should be considered in the
differential diagnosis of patients that have been in
close contact with animals and have a suitable clinical
course.
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